Abosyn, leveraging Medinoah's compliant quality system, is dedicated to the development of cutting-edge API (Active Pharmaceutical Ingredient), advanced intermediates, and related impurities.
Our production facilities are equipped to accommodate the production of clinical and commercial products at various scales, allowing for a flexible transition from kilogram-level to full-scale market production.
Key APIs offered by Abosyn include:
Lipoic acid and R-lipoic acid
Contrast agents such as Gadobutrol
Selective relaxant binding agent such as Sugammadex Sodium
GnRHR Antagonist such as Elagolix Sodium
Antidiabetic such as Teneligliptin
Gabapentinoid such as Mirogabalin Besylate